Ask AI
ProCE Banner Activity

A Patient’s Guide to the Latest Clinical Advances in New Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma 

PDF

This patient-friendly resource summarizes key findings and points from each study on chronic lymphocytic leukemia or small lymphocytic lymphoma. These resources distill each study into a downloadable patient communication document to prepare patients and their healthcare providers for important shared decision-making conversations.

Released: March 03, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Target Audience

This activity is intended for hematologists, oncologists, and other healthcare professionals caring for patients with relapsed/refractory CLL globally.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply recently presented data to clinical practice to expand treatment options and enhance outcomes for patients with relapsed/refractory CLL

  • Appraise the potential clinical implications of new data on novel targeted and cellular therapies for treatment selection and sequencing in patients with relapsed/refractory CLL

  • Support effective shared decision-making through patient education and resources on the potential clinical implications of recently presented data for relapsed/refractory CLL